Foley & Lardner LLP represented Essenvia, a regulatory submission platform for MedTech organizations, in its Series A financing.
Essenvia helps MedTech organizations rapidly submit eSTAR, EUMDR, and IVDR, eliminate common submission errors, and maximize their device’s revenue potential. Unlike conventional Regulatory Information Management (RIM) tools, documents, or spreadsheets, Essenvia has zero technical implementation time and works seamlessly with a regulatory team’s existing process. The platform empowers teams to natively collaborate on 510(k), MDR, and IVDR submissions directly inside of a submission, error check them, dynamically publish and republish them with one click, and instantly submit using the latest agency-specific technical requirements. Essenvia has a 100% acceptance rate across hundreds of different types of complex global submissions.
The funds from the investment round will support company operations, team expansion, product innovation, sales, and distribution.
The Foley team was led by of counsel Alidad Vakili and associates Ashley Lee and Trevor Mullin.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
